Call Options Transactions Made in Q2 2024 in Revance Therapeutics, Inc. (RVNC)
This table provides information about the institutional ownership of Revance Therapeutics, Inc. (RVNC) during Q2 2024. The information is specifically focused on institutions that hold call options of Revance Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2024
Q2 2024
|
Ubs Oconnor LLC
Chicago, IL |
BUY
|
CALL |
120KNew |
$281K - $568K
|
120K
$308K
|
|
|
Aug 14, 2024
Q2 2024
|
Wolverine Trading, LLC
Chicago, IL |
BUY
|
CALL |
2.7K+ 5.79% |
$6.32K - $12.8K
|
49.3K
$127K
|
|
|
Aug 14, 2024
Q2 2024
|
Gts Securities LLC
New York, NY |
SELL
|
CALL |
-2.3K- 8.01% |
$5.38K - $10.9K
|
26.4K
$67.8K
|
|
|
Aug 14, 2024
Q2 2024
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
CALL |
-18.8K- 27.69% |
$44K - $88.9K
|
49.1K
$126K
|
|
|
Aug 14, 2024
Q2 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-39.8K- 40.32% |
$93.1K - $188K
|
58.9K
$151K
|
|
|
Aug 15, 2024
Q2 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-114K- 59.67% |
$266K - $538K
|
76.9K
$198K
|